Conception by Calendar: The Modern IVF Shift to Motherhood | Dr. Abha Majumdar

Reproductive Health · Career & Fertility

Conception by Calendar

How professional women are transforming IVF from a medical last resort into a considered part of career and life planning.

Time influences many of life's defining decisions. As personal aspirations, professional journeys, and future possibilities unfold, new questions are emerging about how people navigate the choices that shape their lives.

For decades, In Vitro Fertilisation was seen strictly through a clinical lens — a stressful medical last resort for couples facing reproductive challenges. That narrative has shifted. Since the world's first IVF birth in 1978, the field has moved from single-digit success rates to figures approaching 50% for women under 35, driven by better stimulation protocols, precision lab techniques, and the ability to freeze eggs and embryos at ultra-low temperatures without losing quality.

Single embryo transfer has also grown more successful, allowing a healthy birth while cutting the risks that come with twin or triplet pregnancies. As these advances have widened what's reproductively possible, IVF has moved beyond treating infertility altogether — it's becoming part of a larger conversation about family planning and reproductive choice.

A shift in mindset

For many women, technologies like egg freezing aren't a backup plan — they're a way to bring the same intention to family planning that they already bring to their careers.

Peak Career vs. Peak Fertility

One of the defining tensions for professional women today is the overlap of two timelines. The years between 25 and 35 are typically the most important for career-building — earning qualifications, establishing credibility, launching businesses, stepping into leadership. Those same years happen to be a woman's peak reproductive window.

A woman's chance of natural conception per cycle sits around 25% in her mid-twenties, and declines meaningfully by 40. That's why the ideal window for elective egg freezing lines up with the same 25–35 range.

10–12
mature eggs needed under age 35 for a reasonable live-birth chance
~20
mature eggs typically needed between ages 35–40
~50%
approximate live birth rate after embryo transfer, under 35

The Career Penalty and the Maternity Wall

An unplanned pregnancy at a critical career moment has long carried real professional cost — for timelines, promotions, and leadership opportunities. Many women have felt pressure to delay conversations about pregnancy out of concern for how they'd be perceived at work.

That culture is changing. HR departments increasingly treat reproductive health as part of employee wellbeing and retention, and companies such as Accenture, Myntra, and Flipkart have begun offering fertility-related benefits — egg freezing, embryo cryopreservation, and IVF support — signalling that career growth and family planning don't have to be either/or.

"Motherhood is no longer a race against time. It is a choice shaped by knowledge, planning, and empowerment."

The Socio-Economic Divide

This progress isn't evenly shared. A single IVF or egg-freezing cycle in India can cost ₹1.5–3 lakh, excluding medication and storage — putting it out of reach for many working women. In practice, the ability to preserve fertility strategically tends to stay concentrated among high-income professionals and employees whose companies offer the benefit, turning a medical advance into an equity question as much as a scientific one.

What Egg Freezing Isn't

It's worth being direct about the limits here: IVF is not a guaranteed insurance policy against age-related fertility decline. Reproductive medicine deals in probabilities, not certainties — success still depends on age, health, embryo quality, and other factors. Freezing eggs during peak reproductive years meaningfully improves the odds of future family-building, but it doesn't remove the possibility of treatment not working. Women considering fertility preservation deserve honest information and realistic expectations, not the sense of a guarantee.

The Real Message

The future of reproductive medicine isn't simply about extending biological timelines. It's about giving women accurate knowledge, more options, and the ability to make informed decisions that fit their own aspirations and life journeys — and about making sure that choice isn't limited to those who can afford it.

About Dr. Abha Majumdar

Prof. Dr. Abha Majumdar is one of India's most respected pioneers in reproductive medicine and assisted reproductive technology. She serves as Advisor and Emeritus Consultant at the Centre of IVF and Human Reproduction, Sir Ganga Ram Hospital, New Delhi. With decades of experience in infertility treatment, IVF, reproductive endocrinology, and women's health, she has contributed extensively to advancing awareness of reproductive health, fertility preservation, and assisted conception as a clinician, educator, researcher, and speaker.

Comments

Popular posts from this blog

Guide to In-Vitro Fertilization, Dr Abha Majumdar

Empowering Women Beyond Medicine- Dr. Abha Majumdar

❌ Missed Periods? Don’t Ignore the Signs! ❌